Dyslipidemias
📧 Sign up to get email alerts when something new happens for Dyslipidemias.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin [Phase 4]
Phase 4 trial update on the efficacy and safety of triple therapy telmisartan/amlodipine/rosuvastatin for hypertension and dyslipidemias.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Cluster Randomized Trial of a Digital Quality Improvement Intervention on LDLCholesterol Control [NA]
A completed cluster randomized trial evaluating a digital quality improvement intervention aimed at improving LDL cholesterol control in peo…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Bialystok Exercise Study in Diabetes [NA]
Medical University of Bialystok reports that the Bialystok Exercise Study in Diabetes has completed, evaluating exercise effects in people w…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Dachundou No Sugar Added Soymilk for Lipid Modulation [NA]
A completed clinical trial from National Taiwan Sport University evaluating Dachundou No Sugar Added Soymilk for lipid modulation in individ…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment [Phase 3]
Phase 3 clinical trial results show efficacy and safety data for Cipros 20 Association in treating dyslipidemias.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients [Phase 1]
Phase 1 study of ARO-ANG3 in healthy volunteers and dyslipidemic patients has completed; the update provides status of the trial.
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: A Phase III Long Term Study of K-877 Extended Release Tablet [Phase 3]
A Phase III long-term study of K-877 Extended Release Tablet for dyslipidemias has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: A Clinical Pharmacology Study of K-877 Controlled Release Tablet [Phase 2]
A completed Phase 2 clinical pharmacology study of the controlled-release tablet form of K-877 (pemafibrate) for dyslipidemias.
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: A Quality Improvement Process to Support Delivery of Cardiovascular Care in Community Mental Health Organizations [NA]
This clinical trial update reports the completion of a Johns Hopkins University–sponsored quality improvement project aimed at enhancing car…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Combining HIIT and n-3 PUFA to Reduce Inflammation and Improve Metabolic Health [NA]
Completed study evaluating the combined effect of high-intensity interval training and omega-3 fatty acid supplementation on inflammation an…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event [Phase 4]
Phase 4 clinical trial evaluating the role of statin therapy in venous dysfunction among patients with venous thromboembolism has completed.…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Medically Tailored Groceries and Food Resource Coaching [NA]
This clinical trial update reports the completion of a study evaluating the impact of medically tailored groceries and food resource coachin…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Trial [NA]
The SphingoFIT trial update reports on a completed study evaluating whether reducing circulating sphingolipid levels can optimize cardiometa…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: A Study of LY3561774 in Participants With Mixed Dyslipidemia [Phase 2]
Phase 2 study of LY3561774 in participants with mixed dyslipidemia completed; trial results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: PocDoc Lipids Out-of-Surgery Study
The PocDoc Lipids Out-of-Surgery Study for dyslipidemias has a completed status according to ClinicalTrials.gov, sponsored by Vital Signs So…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Pueraria Lobata and Pueraria Thomsonii for Mild Dyslipidemia [NA]
This clinical trial update reports a completed study evaluating Pueraria lobata and Pueraria Thomsonii for mild dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab [Phase 4]
A Phase 4 trial evaluated the efficacy and safety of OLOMAX Tab for hypertension and dyslipidemias; the study has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Randomized Study of Obicetrapib as an Adjunct to Statin Therapy [Phase 2]
Phase 2 randomized study of Obicetrapib added to statin therapy has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Real World Evidence Study of Statin Use in Brazil
Clinical trial update reporting a completed real-world evidence study on statin use in Brazil. It evaluated outcomes across cardiovascular d…
-
CLINICAL_TRIALS trial_result · 2024-04-24Clinical Trial Update: Randomized Study of Obicetrapib in Combination With Ezetimibe [Phase 2]
Phase 2 randomized study of Obicetrapib in combination with Ezetimibe for dyslipidemias and high cholesterol has completed with results post…
-
CLINICAL_TRIALS trial_result · 2024-04-24Clinical Trial Update: Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients [Phase 4]
Phase 4 trial assessing efficacy and safety of bempedoic acid combined with anti-PCSK9 therapy and ezetimibe in statin-intolerant patients.
-
CLINICAL_TRIALS trial_result · 2024-02-16Clinical Trial Update: Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins [Phase 4]
Phase 4 trial evaluating the efficacy, safety, and cost-efficacy of a pre-emptive genotyping strategy in patients receiving statins.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities [Phase 4]
Phase 4 trial evaluating safety and effectiveness of saroglitazar 4 mg in patients with NAFLD and comorbidities.
-
CLINICAL_TRIALS trial_result · 2024-01-22Clinical Trial Update: Communicating Health Information and Improving Coordination With Primary Care [NA]
Clinical trial update related to communicating health information and improving coordination with primary care; study completed with posted …
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia [Phase 3]
Phase 3 trial update for a fixed-dose combination of atorvastatin and perindopril in adults with arterial hypertension and dyslipidemia; stu…